Top 50 Medical Startup Investors in United States (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Innova Memphis
VC Fund
|
58 | United States, Argentina, United Kingdom | Seed, Pre-Seed | Health Care, Medical, Medical Device | $25k–$1.7M |
|
ARCH Venture Partners
VC Fund
|
50 | United States, China, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $8.4M–$250M |
|
Alumni Ventures
VC Fund
|
48 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.5M–$79M |
|
Right Side Capital Management
VC Fund
|
41 | United States, Canada, United Kingdom | Seed, Pre-Seed, Convertible Note | Software, SaaS, Health Care | $20k–$2M |
|
General Catalyst
VC Fund
|
39 | United States, United Kingdom, India | Series A, Seed, Series B | Software, Artificial Intelligence, Health Care | $1.8M–$130M |
|
Gaingels
VC Fund
|
39 | United States, Canada, Mexico | Seed, Series A, Series B | Software, Health Care, Artificial Intelligence | $1.1M–$100M |
|
New Enterprise Associates
VC Fund
|
38 | United States, India, United Kingdom | Series A, Series B, Series C | Software, Health Care, Biotechnology | $5.4M–$103M |
|
SOSV
VC Fund
|
37 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Polaris Partners
VC Fund
|
35 | United States, Ireland, Singapore | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $4.5M–$107M |
|
Atlas Venture
VC Fund
|
34 | United States, United Kingdom, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $3.5M–$115M |
|
Alexandria Venture Investments
VC Fund
|
33 | United States, Canada, France | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2M–$150M |
|
Connecticut Innovations
VC Fund
|
33 | United States, Israel, Canada | Seed, Series A | Health Care, Biotechnology, Software | $300k–$25M |
|
Google Ventures
VC Fund
|
32 | United States, United Kingdom, Israel | Series A, Series B, Seed | Software, Health Care, Biotechnology | $1.1M–$121M |
|
OrbiMed
VC Fund
|
32 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $10M–$151M |
|
F-Prime
VC Fund
|
31 | United States, United Kingdom, China | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $9.2M–$165M |
|
Third Rock Ventures
VC Fund
|
30 | United States | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $11M–$190M |
|
Canaan Partners
VC Fund
|
30 | United States, United Kingdom, Israel | Series A, Series B, Series C | Software, Biotechnology, Health Care | $5M–$75M |
|
TEDCO
VC Fund
|
29 | United States, Canada, Colombia | Seed, Grant, Pre-Seed | Health Care, Software, Biotechnology | $25k–$2.5M |
|
Wavemaker 360
VC Fund
|
28 | United States, United Kingdom, Canada | Seed, Series A, Series B | Health Care, Medical, Artificial Intelligence | $750k–$30M |
|
KdT Ventures
VC Fund
|
26 | United States, India, Canada | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $2.6M–$175M |
|
Andreessen Horowitz
VC Fund
|
26 | United States, United Kingdom, Brazil | Series A, Seed, Series B | Software, Information Technology, Artificial Intelligence | $1.6M–$112M |
|
Wisconsin Investment Partners
VC Fund
|
25 | United States, Canada, United Kingdom | Seed, Series A | Health Care, Biotechnology, Medical | $400k–$7M |
|
Lux Capital
VC Fund
|
25 | United States, United Kingdom, Canada | Series A, Seed, Series B | Software, Artificial Intelligence, Health Care | $1.8M–$193M |
|
Rock Health Capital
VC Fund
|
25 | United States, Denmark | Seed, Series A, Series B | Health Care, Software, Medical | $20k–$63M |
|
Versant Ventures
VC Fund
|
25 | United States, Switzerland, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $4.7M–$108M |
|
BioAdvance
VC Fund
|
24 | United States, Canada | Seed, Series A | Biotechnology, Health Care, Medical | $350k–$40M |
|
RA Capital Management
VC Fund
|
24 | United States, United Kingdom, Canada | Series B, Series C, Post-IPO Equity | Biotechnology, Health Care, Therapeutics | $26M–$240M |
|
8VC
VC Fund
|
24 | United States, United Kingdom, Canada | Series A, Seed, Series B | Software, Health Care, Artificial Intelligence | $2.5M–$175M |
|
Khosla Ventures
VC Fund
|
23 | United States, India, United Kingdom | Series A, Series B, Seed | Software, Artificial Intelligence, Health Care | $2M–$100M |
|
StartUp Health
VC Fund
|
23 | United States, Canada, United Kingdom | Seed, Pre-Seed | Health Care, Wellness, Medical | $20k–$4M |
|
Green Park & Golf Ventures
VC Fund
|
23 | United States, Israel, Sweden | Series A, Seed, Series B | Health Care, Medical, Biotechnology | $420k–$45M |
|
Sanofi Ventures
VC Fund
|
22 | United States, United Kingdom, France | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $9M–$150M |
|
MB Venture Partners
VC Fund
|
22 | United States, Israel | Seed, Series B, Series C | Health Care, Medical, Medical Device | $50k–$28M |
|
Asset Management Ventures (AMV)
VC Fund
|
21 | United States, Cyprus, Ireland | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $500k–$35M |
|
Lightspeed Venture Partners
VC Fund
|
21 | United States, India, Israel | Series A, Series B, Seed | Software, Information Technology, Artificial Intelligence | $2.5M–$125M |
|
The Column Group
VC Fund
|
20 | United States | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $9.2M–$115M |
|
Houston Angel Network
VC Fund
|
20 | United States, Canada, France | Seed, Series A | Health Care, Software, Medical | $25k–$5M |
|
Sante Ventures
VC Fund
|
20 | United States, Canada, Japan | Series A, Series B, Series C | Health Care, Medical, Biotechnology | $1.9M–$80M |
|
Qiming Venture Partners
VC Fund
|
20 | China, United States, Hong Kong | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5M–$134M |
|
Portfolia
VC Fund
|
20 | United States, Canada, Romania | Seed, Series A, Series B | Health Care, Biotechnology, Software | $347k–$59M |
|
SpringTide Ventures
VC Fund
|
20 | United States, Israel | Seed, Series A | Health Care, Medical, Software | $1.5M–$14M |
|
Domain Associates
VC Fund
|
20 | United States, Canada, Estonia | Series B, Series C, Series A | Biotechnology, Health Care, Medical | $3.8M–$60M |
|
Everywhere Ventures
VC Fund
|
19 | United States, Australia, India | Pre-Seed, Seed, Series A | Software, Health Care, FinTech | $550k–$60M |
|
Omega Funds
VC Fund
|
19 | United States, Switzerland, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $14M–$208M |
|
Hatteras Venture Partners
VC Fund
|
19 | United States, Canada | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $5M–$90M |
|
Maverick Ventures
VC Fund
|
18 | United States, Israel, India | Series A, Seed, Series C | Health Care, Medical, Software | $2.4M–$145M |
|
Mayo Clinic
VC Fund
|
18 | United States, Canada, Israel | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $100k–$100M |
|
Founders Fund
VC Fund
|
18 | United States, United Kingdom, Germany | Series A, Seed, Series B | Software, Health Care, Information Technology | $1.5M–$100M |
|
Venrock
VC Fund
|
17 | United States, Canada, Switzerland | Series B, Series A, Series C | Health Care, Biotechnology, Software | |
|
First Round Capital
VC Fund
|
17 | United States, Canada, India | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $1.2M–$63M |
| Access all 8122 investors in United States Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Founded in 2007 by the Memphis Bioworks Foundation, Innova is a pre-seed, seed and early-stage investor focused on starting and funding high-growth companies in the Biosciences, Technology and AgBio fields across the state of Tennessee. Innova links capital with great ideas to create groundbreaking products and services.At Innova we invest instart-up companies, help them grow, and then assist them in linking with established corporations for licensing, buy-outs or further investments. We provide the synergy of experienced management, market expertise and venture capital to accelerate the development of new products and services into viable business units that can stand on their own and then take their place with a mature market leader, if desired.Whether an innovation is still on the drawing board or stalled in the market place the Innova staff has the expertise, skills, and experience to envision and create a functioning business unit that is prepared to thrive in the market place. Technical know-how, market-proven staffing, and "just-right" funding assure the greatest chance possible for success.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Pre-Seed
- Geography: United States, Argentina, United Kingdom
Investor stats
- Total investments: 252
- Round size: Seed $50k–$1.7M; Pre-Seed $25k–$1.3M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- HerdDogg — HerdDogg is passionate about livestock. Its innovative data platform sits at the intersection of agtech, the internet of things, and global food security. Our patented DoggTags and DoggBone, together with our Animal Traceability Platform, help producers make more money from every animal they raise. The HerdDogg system enables animal tracking,welfare monitoring and traceability in an easy-to-use application. For more information, visit herddogg.com.
- Insignum AgTech — Insignum AgTech develops biotech plants that communicate with producers, alerting them to an illness in its early stages.
- Rescue Forensics — Customer service is our #1 priority. Get a premium domain for your website today. Financing available.
ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, China, United Kingdom
Investor stats
- Total investments: 414
- Round size: Series A $8.4M–$213M; Series B $14M–$250M; Series C $15M–$175M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Synchron — The endovascular brain computer interface.
- Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
- HI-Bio — HI-Bio leverages human genetic and immunological insights to deliver targeted, effective medicines to patients with immune-mediated diseases.
Access curated startup investment opportunities and diversified venture capital exposure designed for accredited investors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 1791
- Round size: Seed $1.5M–$10M; Series A $5.5M–$37M; Series B $11M–$79M
- Lead/follow: 7% lead, 93% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- NextDroid — NextDroid - We're Doing Something Different
- Enact — Enact is a leading solar energy and solar software company serving homeowners, businesses, and installers. Get a free quote or request a demo today!
- ARRIS — Using next-gen advanced manufacturing technologies, ARRIS Composites produces smarter, lighter, stronger, and more sustainable products at scale.
Systematic Pre-Seed Startup Capital
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 1143
- Round size: Seed $20k–$2M; Pre-Seed $50k–$448k; Convertible Note $50k–$500k
- Lead/follow: 3% lead, 97% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Cohley — Cohley is a content marketing platform focusing on user generated content, visual asset creation, and text review generation. Streamline your content generation today!
- Vidrovr — Vidrovr develops multimodal computer vision and machine learning systems to index, tag, and understand video. It processes videos with specific domain constraints, such as in sports, government, and media verticals. Its technology enables its users to search an indexed video corpus and retrieve content inside videos and link it to other media likephotos and text.The company Integrates social media to enable direct interactions between multimedia content. Vidrovr was founded in 2016 and is headquartered in New York.
- Vector ML Analytics — Vector ML is a financial analytics tool used by executives and analysts at banks and lending institutions to increase return, lower risk, and manage liquidity. It combines treasury, credit risk, FP&A, and capital market features in a single application using AI and automation, allowing for a 360-degree view of the balance sheet. Visit us atwww.vectormla.com
Investing in powerful, positive change that endures
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 1839
- Round size: Seed $1.8M–$20M; Series A $6.5M–$70M; Series B $12M–$130M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Ayr Energy —
- Prosimo — Application Experience across Multi-cloud
- Empathy — Coping with the loss of a loved one is not easy. Download the Empathy App for guidance on what to expect following a loss and the tools to get you through each step.
Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 1006
- Round size: Seed $1.1M–$8.1M; Series A $5M–$40M; Series B $16M–$100M
- Lead/follow: 1% lead, 99% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- BQP — BosonQ Psi Pvt. Ltd. (BQP) is a state-of-the-art SaaS-based enterprise software venture leveraging the power of Quantum computing to speed up virtual simulations of Multiphysics and Computer-Aided Engineering (CAE) nature. BosonQ Psi is at the forefront of this quantum revolution. Our vision is to become the premier multiphysics simulation softwareusing quantum computing. Our world-class software suite will include computational science fields of fluid dynamics, structural dynamics, thermal, chemical, and aeroacoustics. With such an innovative product, we will revolutionize the computational world by enabling high-fidelity simulations that are impossible to solve with current computing technology. Further, this product will aid aerospace, automotive, energy, manufacturing, biotechnology, civil engineering, and astrophysics industries in saving millions of dollars by reducing long turnaround times of simulations used in the design process and give higher accuracy to make significant design changes for giving rise to the next generation of an electric car, eVTOL, skyscraper, or even Mars Rover.The possibility to harness the power of quantum computers is endless, and we at BQP thrive on pushing the boundaries of quantum computing technologies to serve our clients. We have made it our mission to bring these possibilities into the hands of every person - from a researcher to a scientist, from a professor to a student. Our name, BosonQ Psi, pays tribute to the great Indian physicist Dr. Satyendra Nath Bose, after whose name the elementary particle in quantum mechanics, Boson, was named and further incorporates the fundamental quantity that describes the state of the quantum particle - Psi, thus symbolizing the company's fundamental goal to contribute in India's goal to be the leader in the Quantum realm and also become a global leader in Quantum paradigm shift in coming years.
- Willow Wealth — Willow Wealth is an alternative investment platform focused on generating income streams for investors. Get exclusive access to private market investments.
- Hubble Network — Connect a Bluetooth device to a global satellite network, delivering affordable, low-power tracking and monitoring for diverse industrial and commercial applications.
Foundational partners to ambitious founders at every stage of company-building.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1581
- Round size: Series A $5.4M–$60M; Series B $10M–$77M; Series C $14M–$103M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $2.8B in 2022
Portfolio highlights
- IonQ — Working to build the world's best quantum computers to solve the world's most complex problems
- Spyglass Ophthalmics — A vision towards a higher quality of life!
- Xenon Pharmaceuticals — A leading neuroscience company forging new paths for those living with neurological and psychiatric disorders.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Ireland, Singapore
Investor stats
- Total investments: 461
- Round size: Series A $4.5M–$83M; Series B $7M–$107M; Series C $10M–$100M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $182M in 1998
Portfolio highlights
- Living Proof — Living Proof was created for the purpose of applying advanced technology to solve the toughest beauty challenges from a completely fresh perspective. They are a team of scientists from outside beauty, led by MIT Institute Professor Dr. Bob Langer, and beauty authorities with a shared vision: to invent efficient formulas based on entirely newmolecules and breakthrough technologies for results you can see from across the room.
- ReadyForZero — ReadyForZero creates online financial software that helps people tackle any debt and protect their credit - automatically. It's not a "debt negotiation" or "debt settlement" service. The company was co-founded by Rod Ebrahimi and Ignacio Thayer as part of Y Combinator in the Summer of 2010. ReadyForZero is aventure-backed technical product team based in San Francisco.
- Seamless Receipts — Extensive selection of high-quality domain names. Knowledgeable, friendly customer support.
Atlas Venture is an early-stage venture capital firm that creates and invests in biotech startup companies led by promising entrepreneurs focusing on life sciences innovation. Its seed-led venture creation strategy rigorously selects and focuses investment on compelling opportunities to build scalable businesses and realize value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 432
- Round size: Series A $3.5M–$75M; Series B $8M–$115M; Series C $6M–$95M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Grockit — Grockit is a pioneering online social learning company. Grockit has proven that people learn more, faster through combining social learning mechanics and multi-media learning content to help people teach and learn from others. Grockit.com offers Test Prep services for GMAT, IIM CAT, LSAT, GRE, ACT, SAT and AP Calculus and AP History tests.Grockit has built a social learning test prep platform for license and direct-to-consumer products. Florida Virtual Schools, KIPP Schools, Georgetown University and other schools have deployed Grockit services.
- Songbird — DropCatch.com helps you secure expiring domain names.
- Kinaset Therapeutics — Kinaset Therapeutics is a therapeutics company that focuses on the advancement of novel drugs in areas of unmet medical needs. The company was founded in 2020 and is headquartered in Medfield, Massachusetts.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, France
Investor stats
- Total investments: 264
- Round size: Seed $2M–$31M; Series A $12M–$101M; Series B $25M–$150M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- miRecule — MiRecule is an early-stage biotechnology company that focuses on developing microRNA-based therapeutics. It features a genomic-based drug development platform that integrates genomic sequencing, expression, and prognostic data from cancer patients. The company was founded in 2016 and headquartered in Gaithersburg, United States.
- Deep Genomics — Revolutions in AI, biology and automation are enabling a new approach to medicine. Deep Genomics is at the forefront.
- Vedana Therapeutics — Vedana Therapeutics is a Seattle biotechnology company developing next-generation antibody therapies for migraine prevention.
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 259
- Round size: Seed $300k–$5.3M; Series A $2.4M–$25M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $50M in 2023
Portfolio highlights
- 1touch.io — By continuously analyzing traffic and repository stores connected to your network, our network-based solution can detect all elements on the network that are storing, processing, and sharing personal data, both internally and externally. Whether structured or unstructured data, data in motion or at rest, and even data that is unknown to you,1touch.io can track it for you.
- Mobile Sense — The traditional diagnostic market is being transformed by advances in high performance wearables. This seismic shift led by consumer products which are uncovering new patients who previously went undetected, but still require a detailed diagnosis. Mobile Sense™ is building foundational technology that enables this transformation throughoff-the-chest wearables for long term management of cardiac arrhythmias. Developed over 7 years with $4.2M in grant funding and $1.3M in seed funding, Mobile Sense™ has a platform for differentiated wearables. Our embedded algorithms coupled with non-adhesive, wireless & waterproof sensors provides high fidelity continuous ECG and PPG recordings. The automatic monitoring provides 24/7, 365 days/yr continuous detection and classification of dangerous heart arrhythmias.
- LegiTime Technologies — Miami Embracing New Technology and Safety
GV supports innovative founders moving the world forward.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 1110
- Round size: Seed $1.1M–$16M; Series A $6M–$100M; Series B $15M–$121M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $100M in 2014
Portfolio highlights
- Cord Project — Cord is incredibly simple, incredibly fast voice messaging that lets you chat with one friend or shout to a whole group of friends. Start chatting for free on iPhone or Android now.
- Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
- Cambridge Epigenetix — CEGX develops products for academia and industry, democratizing step-changes in accuracy and cost.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 614
- Round size: Series A $10M–$140M; Series B $24M–$151M; Series C $15M–$131M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Fusion Pharmaceuticals — Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company located in Hamilton, Ontario, Canada focused on becoming the leader in the targeted alpha therapy field. It is a spinout of the Centre for Probe Development and Commercialization (CPDC), a leading radiopharmaceutical research and GMP production centre.Fusion’s deepradiochemistry expertise presents a technology platform that can be replicated to turn internalizing antibodies that have previously demonstrated limited clinical efficacy into highly effective cytotoxic drugs. Fusion’s ability to link the most effective isotopes to the targeting antibody allows for the creation of optimized agents for both diagnostic imaging and radioimmunotherapy (Precision Medicine). Following positive tumor identification with the imaging agent, treatment with the antibody linked to a therapeutic isotope delivers a cytotoxic payload into the cancer cell.Fusion’s lead product candidate, FPX-01, is a precision RIT that is a product of this innovative approach. FPX-01 has been designed to internalize into targeted cancer cells and deliver a lethal and highly localized radioactive payload. The precise targeting of this radiolabeled antibody causes selective and extremely effective cytotoxicity of tumor cells at relatively low doses of radioactivity.
- LifeCell International — LifeCell is a research-driven healthcare company with a range of top-notch preventive care & diagnostics services on offer. With more than 3,00,000 happy customers so far, LifeCell is India's largest & most trusted stem cell bank, having state-of-the-art laboratories at Chennai & Gurgaon and a network spread over 200 service centres in the country.
- Harvest Integrated Research Organization — Harvest IRO is a Modern Global CRO providing integrated clinical research organization services and regulatory-ready execution worldwide.
F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, China
Investor stats
- Total investments: 434
- Round size: Series A $9.2M–$87M; Series B $15M–$112M; Series C $22M–$165M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Vestwell — Vestwell is a digital savings platform redefining the way workplace plans are powered today.
- Lemon Cash — Lemon Cash is digital wallet with FIAT and crypto capabilities. End to end digital ecosystem for Latin America.
- Checkmate Pharmaceuticals — Empowering the immune system to beat back cancer
Third Rock Ventures invests in transformational life science companies that show high growth potential and are well-positioned to make a difference in the marketplace. Third Rock Ventures believes in the companies we start and makes significant initial investments, which are frequently supplemented by strategic collaborations, to help our firmsprogress in life-changing medicines, technologies, and diagnostics.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States
Investor stats
- Total investments: 163
- Round size: Series A $19M–$110M; Series B $11M–$190M; Series C $14M–$108M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Corvia Medical — Corvia Medical is a medical device company, focuses on developing structural heart devices for the treatment of heart failure. The company develops InterAtrial Shunt Device (IASD), a transcatheter device designed to treat diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). It was founded in 2009and headquartered in Andover, Massachusetts.
- Jounce Therapeutics — Concentra is a biosciences company.
- Terremoto Biosciences — By unleashing the power of covalent chemistry, we can deliver superior small molecule medicines with enhanced therapeutic benefit.
Canaan is an early stage venture capital firm that invests in entrepreneurs with visionary ideas. With $5B under management, a diversified fund and over 190 exits to date, Canaan has invested in some of the world's leading technology and healthcare companies over the past 30 years. Canaan’s focus areas include fintech, enterprise/cloud,marketplaces, frontier tech, biopharma, digital health, and medtech.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 671
- Round size: Series A $5M–$40M; Series B $8M–$75M; Series C $7.1M–$55M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $100M in 2024
Portfolio highlights
- Lev — Save time, get great rates, and eliminate the paperwork on your next commercial real estate loan. Lev gets you financing in as little as 30 days.
- Berkshire Grey — Berkshire Grey develops a materials handling system intended to automate omnichannel fulfillment. Its system utilizes artificial intelligence, computer vision, machine learning, and novel sensing to deploy intelligent robotic systems that automate tasks never before performed by machines in commercial settings, enabling customers to achieve higheraccuracy and throughput speeds than traditional approaches as well as handle the broadest assortment of products, packaging, and parcels with ease.
- GroundWork — GroundWork delivers Unified Monitoring for Real™ with an open software platform for shockingly easy integrations and customized visualizations of cloud, virtualization, network, application, server, and storage data.GroundWork Monitor is available in free (Core) and subscription versions with support (Enterprise).GroundWork was founded in 2004 andis headquartered in San Francisco, California with partners in Asia Pacific, Europe and South America.
TEDCO is an independent organization that strives to be Maryland’s lead source for entrepreneurial business assistance and seed funding for the development of startup companies in Maryland’s innovation economy.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Grant, Pre-Seed
- Geography: United States, Canada, Colombia
Investor stats
- Total investments: 288
- Round size: Seed $100k–$2.5M; Grant $50k–$1M; Pre-Seed $25k–$900k
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Omni Biosciences — Omni Biosciences is a minority women-owned biotechnology company.
- Nodal Therapeutics — Nodal Therapeutics is a venture-backed startup developing next-generation antigen-specific tolerance technology to stop autoimmune disease.
- Allegany College of Maryland — The main campus of the Allegany College of Maryland rests in Cumberland, off of Willow Brook Road. As the biggest of the school’s three campuses, Cumberland has all of the amenities you may never have expected from a small college. Each building is equipped with the latest modern facilities, making for an up-to-date learning experience. There arealso dining areas, a student lounge, and a state of the art physical education building with a gym and swimming pool.Within the list of extensive fields of study are the social, biological and political sciences, criminal justice and criminology, many fields in the humanities, accounting and business programs, automotive and other technical studies, culinary arts, hotel and restaurant management, forest technology, health fields including dental hygiene, physical education, nursing, and pharmacy technician studies, and more. Advice is not something you’ll be lacking at Allegany. The tutoring services can help you through any academic rough patches. Transfer advising can prepare you to go to a four-year college. Career advising counselors can help you pick a major, assess your interests and aptitudes, and help find you a career.Along with federal financial aid and veteran’s benefits, Allegany also offers a catalog full of scholarships from major related aid to local endowments to eligible students.
Wavemaker Three-Sixty Health is the leading U.S. early-stage (Seed and following on at the Series A) venture capital fund focused 100% on healthcare. Launched in 2018, Wavemaker 360 invested into the most promising healthcare startups in North America, with LPs from every sector of the US healthcare system. We are SEEDING HEALTHCARE'STOMORROW. We invest in healthcare disruptors and entrepreneurs that see how the industry is transforming itself and want to make a big difference.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 85
- Round size: Seed $750k–$6M; Series A $1.9M–$16M; Series B $20M–$30M
- Lead/follow: 12% lead, 88% follow
- Last fund: Likely still investing — raised $64M in 2022
Portfolio highlights
- Tombot — We create robotic animals that transform the daily lives of individuals, families, and communities facing health adversities. Reserve your Tombot Puppy today for FREE
- Lium — Lium provides a platform that structures technical datasets and makes them accessible through natural language, enabling teams to analyze, understand.
- ChemT Biotechnology — The goal of ChemT Biotechnology is to increase patient access to the most cutting-edge biologics, beginning with the urgent issues in manufacturing and research and development.
KdT Ventures is the standard for early-stage frontier science investing.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United States, India, Canada
Investor stats
- Total investments: 93
- Round size: Seed $2.6M–$13M; Series A $8.5M–$70M; Series B $25M–$175M
- Lead/follow: 9% lead, 91% follow
- Last fund: Likely still investing — raised $80M in 2022
Portfolio highlights
- Zag Bio — Zag Bio is harnessing the immune system in a whole new way by targeting the thymus to change treatment possibilities for millions of patients with autoimmune diseases.
- Skeletalis — Skeletalis is a biotechnology startup focused on developing next-generation precision medicines for musculoskeletal diseases, primarily osteoporosis.
- Tacit Therapeutics — Tacit Therapeutics created RNA-targeting treatments for devastating diseases. By repurposing pre-existing components of human cells, we have created the first broadly applicable and inherently non-immunogenic means to repair mutated genes. The company was founded in 2021 and is based in South San Francisco, California.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Andreessen Horowitz (a16z) is a venture capital firm in Silicon Valley, California, investing in bold founders, innovators, and entrepreneurs building the future through technology.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Brazil
Investor stats
- Total investments: 1759
- Round size: Seed $1.6M–$17M; Series A $9M–$55M; Series B $16M–$112M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Tenfold — Tenfold connects systems of engagement and customer data to enable contextual continuous conversations. Get a free demo today.
- Shapeways — Shapeways is the #1 online 3D printing service company. Working with over a million customers since 2007 - Get 3D products and parts delivered to over 100 countries.
- Matik — Remove the data bottleneck & pull numbers, tables, and charts directly into decks and PDFs
Wisconsin Investment Partners is an Angel Investment Group in Madison, Wisconsin founded in 2000 with 20 members. Membership has grown to 50+ members in recent years, bringing significant knowledge and experience.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 115
- Round size: Seed $400k–$3M; Series A $1.1M–$7M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- DropCap — DropCap is a tech-enabled rights agency (dropcap.com) and a global rights marketplace used by rights agents and acquisitions editors around the world to find great books (dropcapmarketplace.com). Our mission is to provide independent authors and publishers access to rights licensing opportunities and help indie books go global through foreignrights, audio, and film rights licensing.
- Cylerity — Transform healthcare receivables into real-time capital. Cylerity unlocks cash flow, clarity, and control from claims data. See how it works.
- Midwest Games — Midwest Games is a video game publisher focused on creating opportunities for the abundant talent across the Midwest and other underrepresented regions.
Lux Capital manages over $5 billion in assets focused on founding, seed, early-stage, and growth investments at the intersection of technology and the sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high-growth sectors. Its investment team has built over 20 companies from scratch. Lux's investmentstrategy ensures portfolio companies are better connected, have a deeper insight, and command industry leadership faster than their competitors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 551
- Round size: Seed $1.8M–$30M; Series A $7.3M–$100M; Series B $13M–$193M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $100M in 2007
Portfolio highlights
- Adimab — Premier Human Antibody Discovery and Optimization
- Kyruus Health — Kyruus Health is a care access platform that provides solutions for providers data management, patient engagement, and activation.
- Cajal Neuroscience — Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.
Rock Health Capital is a full-service seed fund that invests in and supports startups working in digital health. The company invests in entrepreneurs working at the intersection of healthcare and technology. Rock Health Capital is a digital health-focused investment firm.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A, Series B
- Geography: United States, Denmark
Investor stats
- Total investments: 115
- Round size: Seed $20k–$4.2M; Series A $4.7M–$34M; Series B $8M–$63M
- Lead/follow: 6% lead, 94% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- Burst — Burst | FSA & HSA Checkout, Reimbursements, and LMNs anywhere
- No Barrier —
- Rosarium Health — Rosarium Health is a platform that connects service providers (home contractors and occupational therapists) with customers to execute accessible house assessments and accessible home modifications at a client's primary home, leased property, or company.
Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 287
- Round size: Series A $4.7M–$84M; Series B $10M–$105M; Series C $12M–$108M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Graphite Bio — Graphite Bio is a next-generation gene editing company focused on therapies that harness targeted gene integration to treat or cure serious diseases
- Lycia Therapeutics — Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras. The company was founded by Carolyn R. Bertozzi in 2019 and is based in San Diego, California, USA.
- Nested Therapeutics — Nested Therapeutics is a Cambridge-based VC-backed stealth biotech company. The company's focus is on finding and creating new precision oncology small-molecule drugs targeted toward cancer genes. Nested Therapeutics was established in 2021 in Cambridge, Massachusetts.
BioAdvance actively invests venture capital in therapies, medical devices, research tools, diagnostics and health IT in the Mid-Atlantic region.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United States, Canada
Investor stats
- Total investments: 120
- Round size: Seed $350k–$3M; Series A $3M–$40M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — raised $20M in 2002
Portfolio highlights
- Latus Bio — Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients. Latus identified proprietary AAV capsids for clinical use. The company plans to administer low doses of its product candidates, aiming to improve clinical safety and manufacturing.
- Overwatch Health — Overwatch Health offers an AI-assisted virtual rehab for cardiac and pulmonary patients.
- Palvella Therapeutics — Palvella Therapeutics is committed to developing safe and effective therapies that specifically target the root cause of genetic skin diseases.
RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. The company's team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and boardlevels. The company invests in companies with promising technologies and products.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series C, Post-IPO Equity
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 480
- Round size: Series B $26M–$152M; Series C $44M–$183M; Post-IPO Equity $35M–$240M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
- Terrestrial Bio — Vaxess engineers novel technologies that uniquely engage the human immune system, enabling improved efficacy and simplified access for vaccines and therapeutics.
- Kinaset Therapeutics — Kinaset Therapeutics is a therapeutics company that focuses on the advancement of novel drugs in areas of unmet medical needs. The company was founded in 2020 and is headquartered in Medfield, Massachusetts.
8VC is a technology and life sciences investment firm that partners with founders to develop transformational technologies. The firm focuses on creating long-term economic and societal value through its investments across various sectors, including healthcare and logistics.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 525
- Round size: Seed $2.5M–$13M; Series A $8M–$57M; Series B $17M–$175M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Karat — Karat helps companies hire top engineering talent by improving the quality, efficiency, and equity of their technical hiring process
- Apex — Apex manufactures ESPA-class satellites, ranging from 40 to 400kg. Our first spacecraft bus platform, Aries, is built for LEO missions for earth observation, communications, and more. Configure the Aries bus to meet your specific mission profile.
- Flywheel.io — Flywheel is a data management and analysis platform built specifically for scientists and the researcher's workflow. They empower research momentum by focusing on data and medical image capture, content management, scientific computation, and collaboration. With reproducible research in mind, they combine open-source methods from topuniversities, a modern web user interface, and an extensible compute engine based on containerization technology. The result is a software platform to accelerate discovery and help researchers do science, not IT.Flywheel accelerates new scientific discoveries in life-science, biotech, and academic imaging research through cloud-scale collaboration. As a result, imaging researchers are able to avoid innovation bottlenecks, and accelerate discovery by doing more science, and less IT.
Khosla Ventures is a venture capital firm that invests in early- to late-stage companies across sectors like AI, healthcare, sustainability, and consumer technology. It manages multiple funds, focusing on startups with innovative technologies or business models. The firm primarily targets sectors like AI, climate tech, digital health, and medtech,offering strategic support to help build long-lasting companies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Series B, Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1151
- Round size: Seed $2M–$25M; Series A $5.5M–$45M; Series B $10M–$100M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $557M in 2022
Portfolio highlights
- NavigateAI — NavigateAI is an AI copilot for the physical world specifically designed for construction and field service teams to help them complete projects faster, with higher quality, and at lower costs.
- Breeze — Cargo insurance reinvented.
- CHARM Therapeutics — CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more...Investment focus
- Industry: Health Care, Wellness, Medical
- Stage:Seed, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 195
- Round size: Seed $100k–$4M; Pre-Seed $20k–$800k
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Jiseki Health — Jiseki is built on the belief that families and communities need and deserve a safety net, and to have peace of mind when things go wrong. We provide access and delivery of key advice, help, products and services through highly scalable SMS technology, powered by a combination of professionals and AI, and sold as a portable life benefit package..Text #help to 543210, to discover Jiseki services.
- Biome Analytics — Biome is an analytic applications that help cardiovascular teams do their best work. It helps forward thinking hospitals profitably transition and thrive in the new world of healthcare. During COVID-19, Biome has focused on assessing hospital capacity.
- NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Green Park & Golf, built on over 50 years of operational and financial experience, seeks investment opportunities that offer above-market returns for its investors. Led by Clay Heighten, M.D., and Carl Soderstrom, the Firm delivers strategic solutions, financial backing and a reliable network to its portfolio companies. The Dallas-based Firm iscurrently looking for investment opportunities in medical-related start-ups.Dr. Heighten founded MedicalEdge Healthcare Group in 1993, and Mr. Soderstrom started PhyServe Physician Services in 1998 to administer the financial and operational needs of MedicalEdge. Together, the companies managed over 550 providers in five major markets. In 2011, the companies were sold to Texas Health Resources, a $3.8 billion health care system. That’s when Green Park & Golf was born.After earning his MBA at Southern Methodist University, Mr. Garcia joined them full-time in May 2011 to actively pursue new investment opportunities and monitor other investments in their portfolio. He has prior professional experience at FedEx, Bold Ventures, and Lone Star Investment Advisors.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: United States, Israel, Sweden
Investor stats
- Total investments: 93
- Round size: Seed $420k–$3.2M; Series A $1.3M–$18M; Series B $2.1M–$45M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Vellum Health — Vellum Health platform provides on-demand IV enablement & treatment optimized for provider organizations, payers, clinicians, and patients.
- Affineon Health — Affineon is the AI inbox that saves provider time. We automatically handle normal and clinically insignificant lab results, and help providers get through abnormal lab results faster. Our AI automatically groups, analyzes, and trends lab results into a smart summary, including possible next steps and a complete patient note. We also route"noise" to staff, reducing the number of messages a physician needs to pay attention to by up to 30%. The result is 5+ hours saved per week per provider. Plus, Affineon tightly integrates with the EHR, so providers don’t need to change their existing workflow.
- Mobia Medical — MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases. Its therapies include paired vagus nerve stimulation system (Paired VNS System) and wireless neurostimulation system for the treatment of chronic pain, post-stroke upper limb mobility issues, and variousneurological indications that enable healthcare practitioners to treat post-stroke upper limb mobility issues.Founded in 2007, MicroTransponder is headquartered in Dallas, Texas.
Sanofi Ventures invests in top tier biotherapeutic and digital health entrepreneurs who focus on helping patients and transforming the healthcare system.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 119
- Round size: Series A $9M–$140M; Series B $30M–$150M; Series C $30M–$120M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $750M in 2001
Portfolio highlights
- Bionyra — Bionyra Pharma is a clinical-stage biopharmaceutical startup developing next-generation biologics for serious immune-mediated inflammatory diseases.
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases.
- Star Therapeutics — Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
MB Venture Partners in Memphis, TN provides venture capital for life sciences: medical device, biotechnology companies, products for musculoskeletal diseases
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Series B, Series C
- Geography: United States, Israel
Investor stats
- Total investments: 90
- Round size: Seed $50k–$700k; Series B $1.3M–$18M; Series C $5M–$28M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $22M in 2011
Portfolio highlights
- Cast21 — The future of orthopedic technology has arrived. Cast21 braces are designed for your active lifestyle.
- SweetBio — SweetBio is a Memphis, Tennessee based medical device company specializing in bioengineering honey-incorporated materials for wound care.
- Lineus Medical — Lineus Medical is a medical device company focused on reducing IV complications for patients and providers all over the world.
AMV is the leading early-stage venture capital firm investing in digital health, technology and life sciences. It has assembled the leading early-stage
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: United States, Cyprus, Ireland
Investor stats
- Total investments: 145
- Round size: Seed $500k–$6M; Series A $2.4M–$21M; Series B $5M–$35M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — raised $150M in 2020
Portfolio highlights
- SeeQC — SEEQC is developing the first digital quantum computing platform for businesses. SEEQC combines classical & quantum technologies to address the efficiency, stability & cost issues endemic to quantum computing.
- Outcomes4Me — Outcomes4Me is empowering cancer patients globally with treatment options, medical records, and clinical trials all in one app.
- Autonomize AI — AI That Runs Healthcare. For the Humans Who Make It Work. AI-Native Infrastructure: Rewiring Healthcare Operations for the Next Era.
Lightspeed Venture Partners is a multi-stage venture capital firm focused on accelerating disruptive innovations and trends.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, India, Israel
Investor stats
- Total investments: 1704
- Round size: Seed $2.5M–$30M; Series A $7M–$95M; Series B $13M–$125M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $2.4B in 2022
Portfolio highlights
- Razorpay — Online Payments India: Start Accepting Payments Instantly with Razorpay's Payment Suite, which Supports Netbanking, Credit Card & Debit Cards, UPI etc.
- Matillion — Enterprise level data integration tools built for the cloud. Harness your data into transformative business insights. Your data is your competitive edge.
- Ricursive Intelligence — We develop frontier AI methods to reinvent chip development, collapsing traditional design timelines, closing the loop between AI and the hardware that fuels it, and enabling a Cambrian explosion of custom silicon.
The Column Group (TCG) is a venture ecosystem dedicated to fueling scientific innovation in the life sciences industry.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States
Investor stats
- Total investments: 141
- Round size: Series A $9.2M–$102M; Series B $22M–$115M; Series C $33M–$107M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Peloton Therapeutics — Peloton Therapeutics is translating groundbreaking scientific insights into first-in-class oral medicines to fight cancer and other serious conditions.
- NGM Biopharmaceuticals — Our broad, diverse pipeline of novel, first-in-class medicines spans multiple therapeutic areas and diseases. Every program focuses on a large market indication with high unmet needs and a common goal: delivering outsized impact for patients.
- Constellation Pharmaceuticals — Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.
The Houston Angel Network (HAN) is a nonprofit organization dedicated to developing the innovation ecosystem in Houston, Texas by supporting founders and startups with financial resources and mentorship.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A
- Geography: United States, Canada, France
Investor stats
- Total investments: 133
- Round size: Seed $25k–$1.8M; Series A $240k–$5M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- ITeam — iTeam is transforming the way information technology (IT) and audio/video (A/V) installation services are packaged, sold and delivered through a new approach called Service-as-a-Product™ (SaaP™).
- Monster Mosquito — Monster Mosquito focuses on providing all-natural mosquito sentry repellent systems for its clients. The company also develops a biodegradable compound insecticide to exterminate biting insects.Monster Mosquito uses mosquito mist systems, which contains pyrethrum, a natural mosquito killer made from chrysanthemums. The company was founded in 2002by Kemper Modlin and Leo Niekerk.It is based in Spring, Texas.
- Quarri Technologies — Quarri is a leading provider of on demand web browser information security solutions that secure information and content at the endpoint. Their products give enterprises the ability to extend security controls temporarily to web browsers accessing their web applications, providing information protection and data leakage prevention wherever yourusers are.
Privately Held Companies
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: United States, Canada, Japan
Investor stats
- Total investments: 118
- Round size: Series A $1.9M–$32M; Series B $2.6M–$61M; Series C $5M–$80M
- Lead/follow: 62% lead, 38% follow
- Last fund: Likely still investing — raised $260M in 2021
Portfolio highlights
- REVELOHEALTH — REVELOHEALTH provides advisory services. Their services include healthcare provider solutions, revenue cycle solutions, price transparency solutions, payment integrity, network claim repricing, data analytics, denial management, and direct-to-employer.
- Sonire Therapeutics — Sonire Therapeutics provides High-Intensity Focused Ultrasound treatment for cancer.
- SONIRE Therapeutics — SONIRE Therapeutics is a clinical-stage medical device company. It is a U.S. subsidiary of SONIRE Therapeutics Co., Ltd..
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 803
- Round size: Series A $5M–$68M; Series B $9.4M–$100M; Series C $14M–$134M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $887M in 2023
Portfolio highlights
- Nice Tuan — Nice Tuan is an e-commerce platform that provides daily groceries and miscellaneous products.
- Twine Health — Fitbit Health Solutions' wellness and health solutions can help keep your population healthy and drive meaningful employee engagement. Learn more.
- WindMIL Therapeutics — WindMIL Therapeutics translates novel insights in bone marrow immunology into life-saving cell therapies for cancer patients. The company leveraging its proprietary platform to develop a novel class of cell therapies called MILs (Marrow Infiltrating Lymphocytes) derived from memory T cells found in the bone marrow. WindMIL Therapeutics wasestablished in 2015 and is based in Baltimore, MD.
Investing Funds Designed for Women Backing Innovative Companies We Want in the World - For Returns and Impact
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Romania
Investor stats
- Total investments: 187
- Round size: Seed $1.2M–$4.3M; Series A $347k–$15M; Series B $9M–$59M
- Lead/follow: 2% lead, 98% follow
- Last fund: Likely still investing — raised $722k in 2022
Portfolio highlights
- Schola — Schola helps families find and enroll in the ideal PreK-12 schools.
- Aria CV — Learn about Aria CV's novel implantable medical device designed to treat pulmonary hypertension (PH). Our elegant device has no battery, pump, or electronics.
- Health Hero — Conscious health engagement for patients, employees, and health plan members. A digital platform elevating one's health by promoting a natural way of life considering the social determinants of health - by delivering engaging, simple, & personalized programming through any medium.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!SpringTide is a venture capital that provides investment in the health tech industry. The firm was founded in 2018 and is headquartered in Cambridge, Massachusetts, United States.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Series A
- Geography: United States, Israel
Investor stats
- Total investments: 46
- Round size: Seed $1.5M–$9.3M; Series A $2.1M–$14M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $65M in 2022
Portfolio highlights
- Pathology Watch — Pathology Watch delivers an intuitive and easy-to-implement digital pathology solution for dermatologists. They work with clinical dermatology practices to digitize the pathology workflow, which is helping to improve the quality of patient care, reduce costs, and open up new potential streams of revenue for clinics and hospitals. They also deliveran intuitive and easy-to-implement digital pathology solution that includes access to top-tier Dermatopathologists.It was founded in 2017 and is based in Salt Lake City, Utah.
- Prolucent Health — Secure the workforce you need for today and tomorrow. We are leading the change needed to meet workforce demands in healthcare through innovation and thoughtful transformation. Permanent Flex Pools Contingent Prolucent creates a unified Approach to meet your workforce demands. Attract, convert and retain talent through AI-powered technology & custom strategies informed by data analytics
- Vigor — A digital health platform for managing chronic respiratory diseases Vigor Learn More
INVESTMENT ADVISORS TO THE FIRST VC FUND DEDICATED TO BIOTECH INVESTMENT MANAGER OF 9 SUBSEQUENT BIOTECH VC FUNDS
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series C, Series A
- Geography: United States, Canada, Estonia
Investor stats
- Total investments: 194
- Round size: Series A $3.8M–$50M; Series B $10M–$60M; Series C $10M–$57M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — raised $164M in 2016
Portfolio highlights
- Bionano Genomics — Discover how Bionano is striving to elevate health and wellness for all through optical genome mapping (OGM) solutions that transform the way the world sees the genome.
- Epic Sciences — Epic Sciences develops clinical solutions that accelerate drug development and guided therapy across cancer drug indications. Epic's new AR-V7 CTC liquid biopsy test is the first clinically proven predictive test for metastatic castration-resistant prostate cancer.
- Fractyl Health — Fractyl Health develops innovative medical device solutions for the treatment of chronic diseases. The growing product pipeline leverages our minimally invasive procedural therapy, Revita DMR (duodenal mucosal resurfacing), which is designed to rejuvenate the lining of the duodenum and improve patient health. They envision a world with bettersolutions to chronic diseases through the use of less invasive, device-based therapies that will lessen the burden on patients, physicians, and payers.Fractyl Health aims to bring curative therapies to the large populations of patients with metabolic disease.
Everywhere Ventures is a global pre-seed venture capital fund for founders, by founders. Click to read Everywhere VC, by Everywhere Ventures, a Substack publication with tens of thousands of subscribers.
Show more...Investment focus
- Industry: Software, Health Care, FinTech
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, Australia, India
Investor stats
- Total investments: 711
- Round size: Seed $1.5M–$7.2M; Pre-Seed $550k–$2.6M; Series A $10M–$60M
- Lead/follow: 2% lead, 98% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Donna — Meet Donna, the AI assistant built for field sales teams. Save time, cut admin, and close more deals with less effort.
- VAMA — VAMA is a one-stop virtual platform that provides easy access to e-pujas, e-darshans, and astrology services, to devotees from across India and the world.
- Suma Wealth — SUMA is a revolutionary financial wellness company with the mission to engage, educate, and empower the Latinx community via a holistic approach of Digital Media, Experiences, and FinTech. By creating culturally relevant content, virtual experiences, and providing financial tools that demystify and reimagine financial wellness throughentertainment, we aim to become the trusted source to help Latinos own their economic power, overcome financial challenges, and better prepare for a more prosperous future.
We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 154
- Round size: Series A $16M–$197M; Series B $35M–$162M; Series C $14M–$208M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Attenua — 100% satisfaction guaranteed. Hassle-free shopping. We help you find the right domain name.
- Ousia Pharma — Ousia Pharma is paving the way for novel therapeutic strategies using peptide-drug-conjugates
- Andrew Alliance — OneLab is laboratory software to design and execute liquid handling protocols. Pipette+ for manual liquid handling pipetting and Andrew+ the pipetting robot
Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine. Founded in 2000, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to buildingsuccessful new biomedical companies. The Hatteras Venture Partners team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With three funds, the firm has more than $120 million under management.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Canada
Investor stats
- Total investments: 131
- Round size: Series A $5.2M–$50M; Series B $5M–$90M; Series C $8M–$88M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Ribometrix — The Next Frontier of Drug Discovery
- G1 Therapeutics — G1 Therapeutics is a clinical-stage company developing novel cancer therapies. It was founded in 2008 by Drs. Norman Sharpless and Kwok-Kin Wong to capitalize on discoveries made and patented by Dr. Sharpless’ lab at the University of North Carolina at Chapel Hill, and subsequently licensed to G1 Therapeutics. Trilaciclib is an investigationaltherapy designed to improve outcomes for people with cancer who are treated with chemotherapy. G1 is also advancing rintodestrant, a potential best-in-class oral selective estrogen receptor degrader, or SERD, for the treatment of ER+ breast cancer.
- Viamet Pharmaceuticals — Viamet Pharmaceuticals discovers and develops "best-in-class" inhibitors of validated metalloenzymes via an innovative and proprietary metal-binding approach, their Metallophileâ„¢ Technology. Viamet's disruptive Metallophileâ„¢ technology is based on their world-class expertise in bioinorganic chemistry and metalloenzymes and allowsthem to identify validated targets with high therapeutic and commercial potential; leverage existing metalloenzyme inhibitors as the basis for Viamet's best-in-class analogs; and rapidly and cost-effectively generate best-in-class, patentable, small molecule compounds by optimizing the metal-binding component of existing inhibitors.
Maverick Ventures is the venture arm of multi-billion dollar investment firm Maverick Capital. Combining the resources of a global firm with the benefits of an agile, focused team, Maverick Ventures supports entrepreneurs from seed through maturity. With over 30 years of early-stage investment experience, the Maverick Ventures team has funded morethan 100 companies in the healthcare, software and deep technology sectors. The highly-experienced team of operating executives and investors at Maverick Ventures generally lead rounds, take board seats and work with management to build successful enterprises.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Series A, Seed, Series C
- Geography: United States, Israel, India
Investor stats
- Total investments: 186
- Round size: Seed $2.4M–$10M; Series A $6M–$40M; Series C $10M–$145M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $382M in 2019
Portfolio highlights
- Infleqtion — Infleqtion delivers high-value quantum information precisely where needed. Based on ColdQuanta's pioneering quantum research, their Edge-based products offer unmatched precision and power. Addressing critical needs in PNT, global communication security, energy distribution, and quantum computing, In
- Adentro — Zenreach created Walk-Through Marketing to help businesses with physical locations dramatically improve customer acquisition and lifetime value by connecting digital marketing with in-store results. Zenreach Engage automatically tracks customer visits, effortlessly builds rich customer profiles and keeps them up to date. Zenreach Attract improvesad performance 4x by targeting audiences based on your best customers. Results are measured with our Walk-Through Rate™, a proprietary metric that shows when someone exposed to an ad visits a location. Founded in 2012, Zenreach serves thousands of independent merchants and leading brands like Peet’s Coffee, Ruth’s Chris and BCBG Max Azria.
- Belong Health — Fully supportive healthcare, now available to everyone. Dedicated, comprehensive care for the Medicare + Medicaid-eligible community.
Mayo Clinic, a not-for-profit medical group practice, provides medical care, research, and education services. It offers medical care services in various specialties, including diabetes and endocrinology, gastroenterology, gynecology, cancer, neurology and neurosurgery, orthopedics, pulmonology, rheumatology, nephrology, urology, and cardiology andheart surgery.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 110
- Round size: Seed $100k–$6M; Series A $3.5M–$40M; Series B $8M–$100M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- ViewsML — Explore cutting-edge AI solutions for cancer treatment, diagnosis, and research. Discover how clinical labs leverage artificial intelligence for precise cancer detection and diagnosis.
- SyntaxBio — SyntaxBio develops CRISPR/Cas9-based, genetic programming platform that converts cells into biological computers using DNA-based instructions that read like lines of code. SyntaxBio's platform can program cells without the need for consistent external intervention.
- Techcyte — Techcyte is an AI software platform for clinical pathology that leverages machine learning for quicker, more efficient diagnoses for laboratories and patients.
Founders Fund is a San Francisco based venture capital firm investing in companies building revolutionary technologies.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 821
- Round size: Seed $1.5M–$16M; Series A $5.6M–$50M; Series B $15M–$100M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Quantcast — We are taking an entirely new approach to advertising on the open internet.
- Workstream — Workstream is an automated hiring platform that helps companies employing hourly workers. The platform helped Jamba, Chick-fil-A, McDonald's, Dunkin', Applebee's, Auntie Anne's, Cinnabon to increase their bottom line and cost savings.Workstream was founded in 2017 and is headquartered in San Francisco, California, UnitedStates.
- Valinor Enterprises — Valinor is a new kind of defense and government tech company. We build and buy mission-critical technologies to fill the gaps others ignore.
Building Companies that Shape the Future
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series B, Series A, Series C
- Geography: United States, Canada, Switzerland
Investor stats
- Total investments: 470
- Lead/follow: no public data
Portfolio highlights
- Oumi — Building truly open, reliable frontier AI.
- Suki — Suki is an AI-powered voice assistant that lifts the administrative burden from clinicians, so they have time to focus on what matters - patient care.
- GenLogs — Get ready to have your operations supercharged! Our real-time data on all trucks in America helps you find the right capacity at the right time.
First Round is a seed-stage venture firm focused on building a vibrant community of technology entrepreneurs and companies.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, India
Investor stats
- Total investments: 821
- Round size: Seed $1.2M–$8.6M; Series A $2.3M–$26M; Series B $7M–$63M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- treet — Treet helps brands launch fully-branded recommerce sites where customers can buy & sell items from each other.
- Aisera — Aisera's AI Service Management (AISM) solution helps enterprises to automate IT tasks & workflows to deliver exceptional service experience.
- PullString — PullString, Inc. is leading the field of computer conversation in both text and voice through a combination of design and technology. PullString (formerly ToyTalk) is an entertainment and technology company combining art and science to enable computer conversation with characters.The company's primary product, the PullString Platform, offersa professional authoring environment, hosted AI and machine learning runtime, and integrated conversation analytics to enterprises, agencies, and startups across verticals as diverse as entertainment, customer service, gaming and VR, travel, automotive, health and fitness, finance, human resources, and IoT.With direct support for all major conversational platforms like Facebook Messenger, Amazon Alexa, Skype, Slack, Kik, mobile, and web, the PullString Platform has been used to create award winning experiences like Call of Duty’s Lt Reyes on Messenger, Hello Barbie, and The Winston Show.PullString, founded as ToyTalk in 2011, has raised more than $44 million in funding from Greylock Partners; Charles River Ventures; Khosla Ventures; True Ventures; and First Round Capital.
Medical Investor funding in United States at a glance
Stats across 11k deals from 8.1k investors.
Access all 8122 investors in United States Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Investors in United States investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 8122 investors investing in United States Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!